The Lancet thelancet.com

[Therapeutics] Pyruvate kinase activators in hereditary haemolytic anaemias: current evidence and clinical potential

thelancet.com·10w

[World Report] Syria's missing: rebuilding forensic identification

thelancet.com·10w

[Correspondence] Nipah virus: a regional threat south Asia keeps underestimating

thelancet.com·10w

[Perspectives] Bill Foege: building global health coalitions with compassion

thelancet.com·10w

[Comment] Offline: The human consequences of Epic Fury

thelancet.com·10w

[Correspondence] Call to enhance civilian and military blood preparedness

thelancet.com·11w

[Correspondence] Time to change internal medicine training for UK resident doctors

thelancet.com·11w

[Perspectives] Cancer in pregnancy: navigating two medical systems

thelancet.com·11w

[Correspondence] Changes in paracetamol and leucovorin use after a White House briefing

thelancet.com·11w

[World Report] The boom in counterfeit obesity drugs

thelancet.com·11w

[Articles] Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial

thelancet.com·11w

[Comment] Pimicotinib: a new agent for an orphan disease

thelancet.com·11w

[Comment] Considerations for improving non-inferiority trials

thelancet.com·11w

[Viewpoint] Health justice

thelancet.com·11w

[Correspondence] The need for improved sexual health among survivors of sex trafficking

thelancet.com·12w

[Correspondence] Trump claims Venezuela does not meet trafficking standards—but what about the USA?

thelancet.com·12w

[Comment] Safeguarding genomic integrity in pluripotent stem-cell therapies

thelancet.com·12w

[Review] Autosomal dominant polycystic kidney disease

thelancet.com·12w

[Seminar] Sepsis

thelancet.com·12w

[Correspondence] Misinformation harms medicine

thelancet.com·12w

Log in to enable infinite scrolling